Zephyrnet Logo

Tag: Breast cancer

22 Video Marketing & Advertising Campaigns You’ll Actually Enjoy Watching

91% of people want to see more video marketing efforts from brands — but knowing where to start can be intimidating. We’re sharing 22...

Medical physics and biotechnology: highlights of 2023 – Physics World

This year, the Physics World team selected a medical innovation as the Breakthrough of the Year: the development of a digital bridge that restores...

Koning Health and Gentle Scan Health Announce Partnership to Enhance Breast Cancer Detection Across the United States with 20 New Devices | BioSpace

NORCROSS, Ga., Dec. 18, 2023 /PRNewswire/ -- Koning Health, the leading innovator in breast CT technology, and Gentle Scan Health, LP, a venture firm...

Ultrasonic 3D Printer Could One Day Repair Organs in the Body Without Surgery

A plump piece of farm-fresh chicken leg rested on a pristine surface at Harvard Medical School. Skin on and bone in, it was precisely...

Associating growth factor secretions and transcriptomes of single cells in nanovials using SEC-seq – Nature Nanotechnology

Uhlén, M. et al. Tissue-based map of the human proteome. Science 347, 1260419–1260419 (2015).Article  ...

You’re my hero

Key points: I’ve always hated being put on the spot to answer some version of this question: “Who is your role model?  Who inspired your...

RSNA 2023 showcases AI in radiology – Physics World

RSNA 2023, the annual meeting of the Radiological Society of North America (RSNA) takes place this week in Chicago, showcasing recent research advances and...

CAR T Cell Immunotherapy And The Quiet Hope For A Universal Cancer Treatment

All of us have to deal with the looming threat of developing cancer during our lifetime, no matter how good our genetics are, or...

RTI Surgical Inc. Receives FDA IDE Approval for the Clinical Investigation of Cortiva® Allograft Dermis in Breast Reconstruction | BioSpace

ALACHUA, Fla., Nov. 27, 2023 /PRNewswire/ -- RTI Surgical, a leading global medical device organization, announced that the U.S. Food and Drug Administration (FDA)...

Time to look Beyond Compulsory Licenses? A Glimpse at the Ribociclib Case

. Recently, the Print reported that Novartis and Eli Lilly have voiced their opposition to the idea of compulsory licensing (“CL”) for breast cancer medications,...

Latest Intelligence

spot_img
spot_img

Chat with us

Hi there! How can I help you?